Answers are grounded in this paper and cite their sources.
In principle, there are three defined procedures to obtain approval for a medicinal product in the European Union. As discussed in this overview of the procedures, the decision on which regulatory pathway to use will depend on the nature of the active substance, the target indication(s), the history of product and/or the marketing strategy.
No takes yet. Share an insight, caveat, or question.
Manuela Kohler (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: